Source link : https://newshealth.biz/health-news/asandeutertinib-tops-osimertinib-for-nsclc-with-brain-mets/
In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases. Medscape Medical News Source link : https://www.medscape.com/viewarticle/asandeutertinib-tops-osimertinib-egfr-nsclc-brain-metastases-2026a1000i5p?src=rss Author : Publish date : 2026-06-01 12:01:00 Copyright for syndicated content belongs to the linked Source.
The post Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-01 12:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8